Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
This review article comprehensively examines the role of nanotechnology in advancing medical science, with a focus on its applications in drug delivery, diagnostics, and tissue engineering. We explore the classification of nanomaterials based on dimensionality, composition, and dispersion, and discuss their critical role in revolutionizing medicine. Nanomaterials such as liposomes, protein-based nanoparticles, and dendrimers are highlighted for their ability to enhance drug delivery systems, improving targeting, bioavailability, and reducing side effects. We investigate theranostics, where nanoparticles integrate diagnostic imaging and treatment capabilities in a single platform, enabling more effective cancer therapies through targeted drug delivery. The article also covers advancements in tissue engineering, where nanomaterial-based scaffolds are used to regenerate damaged tissues and organs. We present novel developments in creating bioinspired scaffolds using chitosan, cellulose, and graphene oxide, which improve cell adhesion and enhance mechanical properties for tissue regeneration. The review also discusses the nanoparticles’ potential in bioimaging tools such as MRI, PET, and fluorescent imaging. We highlight cutting-edge developments in nanoparticle-based contrast agents that improve imaging accuracy and enable real-time monitoring of therapeutic interventions. Our review stands out by integrating recent advancements in the multifunctional use of nanomaterials for personalized medicine. We address the challenges of toxicity, regulatory concerns, and the future potential of nanotechnology in clinical translation, positioning this work as a significant contribution to the field of nanomedicine. Nanomedicine is an emerging field that harnesses the unique properties of nanomaterials to revolutionize healthcare, offering significant advances in diagnostics, targeted drug delivery, therapeutic interventions, and tissue engineering. This review comprehensively examines the various categories of nanomaterials, including metal-based (e.g., gold and silver), carbon-based (e.g., graphene and carbon nanotubes), organic (e.g., dendrimers and liposomes), and hybrid materials, highlighting their potential applications in drug delivery, bioimaging, and theranostics. Nanomaterials are utilized for their ability to improve drug bioavailability, target specific tissues, and enable precise control over drug release, making them highly effective in treating diseases like cancer and neurological disorders. The review explores the mechanisms and clinical applications of key imaging technologies such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), fluorescence, and surface-enhanced Raman scattering (SERS), where nanomaterials significantly enhance sensitivity, resolution, and tissue penetration. Additionally, the role of aggregation-induced emission (AIE) in fluorescence imaging and the promise of nanoparticle-based theranostic platforms—integrating both diagnostic and therapeutic functions—are discussed in depth. These multifunctional nanoparticles have the potential to revolutionize personalized medicine by offering precise disease monitoring and treatment simultaneously. Further, the review delves into the clinical progress and regulatory aspects of nanomedicine, noting recent advancements in clinical trials and approved therapies, including mRNA-based vaccines and targeted nanomedicine therapies for cancer. The development of nanoparticle-based scaffolds for tissue regeneration and their integration into clinical practice are also highlighted, alongside challenges in biocompatibility, toxicity, and scalability. The discussion includes insights into patents, ongoing clinical studies, and the road ahead for overcoming current limitations in nanomedicine. This review provides a holistic view of the state of nanomedicine, offering a comprehensive understanding of its current and future impact on healthcare, therapeutic efficacy, and clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Arora, S., Layek, B., & Singh, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00461 · Cited by 149
Cited by
PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances
Stevanović, M. M., Qian, K., Huang, L., & Vukomanović, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121613 · Cited by 42
“Particle size directly influences crossing biological barriers and biodistribution, cellular uptake, and clearance rates; smaller nanoparticles (<200 nm) typically enhance tissue penetration and circulation time, while larger particles may provide sustained local release [60].”
Metadata
- Authors
- Kurul, F., Turkmen, H., Cetin, A. E., & Topkaya, S. N.
- Venue
- Next Nanotechnology
- Publisher
- Elsevier BV
- Published
- 2025
- Volume
- 7
- Pages
- 100129
- ISSN
- 2949-8295 (ISSN-L)
- OpenAlex
- W4406071921
- Cited by
- 248
- References
- 7
- FWCI
- 58.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis. https://app.cochat.ai/papers/10.1016/j.nxnano.2024.100129
- The paper
- Kurul, F., Turkmen, H., Cetin, A. E., & Topkaya, S. N. (2025). Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis. Next Nanotechnology. https://doi.org/10.1016/j.nxnano.2024.100129
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.